Tandem Diabetes Care

ISIN US8753722037

 | 

WKN A2H5BX

Market cap (in EUR)
1,308 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
Show more Show less
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices United States

Financials

Key metrics

Market capitalisation, EUR 1,308 m
EPS, EUR -2.76
P/B ratio 11.5
P/E ratio -
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 869 m
Net income, EUR -89 m
Profit margin -10.21%

What ETF is Tandem Diabetes Care in?

There are 5 ETFs which contain Tandem Diabetes Care. All of these ETFs are listed in the table below. The ETF with the largest weighting of Tandem Diabetes Care is the Global X Telemedicine & Digital Health UCITS ETF Acc USD.
ETF Weight Investment focus Fund size (in m EUR)
Global X Telemedicine & Digital Health UCITS ETF Acc USD 1.32%
Equity
World
Health Care
5
iShares S&P SmallCap 600 UCITS ETF 0.07%
Equity
United States
Small Cap
1,758
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
495
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.00%
Equity
North America
Social/Environmental
27
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.02%
Equity
United States
Small Cap
182
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.